The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for cancer, AIDS, multiple sclerosis and other serious maladies far over the ...
We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
The nation’s three largest PBMs – CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx – inflated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback